Trial Details

TERMINATED
Basic Information
Clinical ID c4036
Identifier NCT01150890
Trial Title Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions BIOLOGICAL: Brodalumab|DRUG: Placebo
Participant Information
Sponsor Amgen
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2010-11-09
Primary Completion Date 2011-10-15
Completion Date 2011-10-15